Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal L Benowitz

Showing results (151-160 of 427) with videos related to

Pageof 43
Sort By:
Pharmacogenetics and Genomics|January 25, 2013
Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady stateNeal L Benowitz, Andy Z X Zhu, Rachel F Tyndale, et al.
Drug and Alcohol Dependence|July 7, 2017
Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependencyNoah R Gubner, Joseph Guydish, Gary L Humfleet, et al.
Drug and Alcohol Dependence|September 11, 2007
Cytisine for smoking cessation: a research agendaJean-François Etter, Ronald J Lukas, Neal L Benowitz, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 13, 2006
Biomarkers to assess the utility of potential reduced exposure tobacco productsDorothy K Hatsukami, Neal L Benowitz, Stephen I Rennard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigaretteNeal L Benowitz, Sharon M Hall, Susan Stewart, et al.
Pharmacogenomics|February 9, 2010
New CYP2A6 gene deletion and conversion variants in a population of Black African descentJill C Mwenifumbo, Qian Zhou, Neal L Benowitz, et al.
Pharmacological Reports : PR|April 9, 2018
Slower nicotine metabolism among postmenopausal Polish smokersLeon Kosmider, Marcin Delijewski, Bartosz Koszowski, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 24, 2019
The Role of Compensation in Nicotine ReductionNeal L Benowitz, Eric C Donny, Kathryn C Edwards, et al.
Clinical Toxicology (Philadelphia, Pa.)|February 20, 2019
Loperamide associated torsades de pointes, in the setting of complete heart block at marginally supratherapeutic dosing (20mg/day)Robert Goodnough, Mariko Nomura, Adina Badea, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 22, 2006
Biomarkers to assess the utility of potential reduced exposure tobacco productsDorothy K Hatsukami, Neal L Benowitz, Stephen I Rennard, et al.
Pageof 43

Showing results (151-160 of 427) with videos related to

Sort By:
Pageof 43
Pharmacogenetics and Genomics|January 25, 2013
Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady stateNeal L Benowitz, Andy Z X Zhu, Rachel F Tyndale, et al.
Drug and Alcohol Dependence|July 7, 2017
Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependencyNoah R Gubner, Joseph Guydish, Gary L Humfleet, et al.
Drug and Alcohol Dependence|September 11, 2007
Cytisine for smoking cessation: a research agendaJean-François Etter, Ronald J Lukas, Neal L Benowitz, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 13, 2006
Biomarkers to assess the utility of potential reduced exposure tobacco productsDorothy K Hatsukami, Neal L Benowitz, Stephen I Rennard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigaretteNeal L Benowitz, Sharon M Hall, Susan Stewart, et al.
Pharmacogenomics|February 9, 2010
New CYP2A6 gene deletion and conversion variants in a population of Black African descentJill C Mwenifumbo, Qian Zhou, Neal L Benowitz, et al.
Pharmacological Reports : PR|April 9, 2018
Slower nicotine metabolism among postmenopausal Polish smokersLeon Kosmider, Marcin Delijewski, Bartosz Koszowski, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 24, 2019
The Role of Compensation in Nicotine ReductionNeal L Benowitz, Eric C Donny, Kathryn C Edwards, et al.
Clinical Toxicology (Philadelphia, Pa.)|February 20, 2019
Loperamide associated torsades de pointes, in the setting of complete heart block at marginally supratherapeutic dosing (20mg/day)Robert Goodnough, Mariko Nomura, Adina Badea, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 22, 2006
Biomarkers to assess the utility of potential reduced exposure tobacco productsDorothy K Hatsukami, Neal L Benowitz, Stephen I Rennard, et al.
Pageof 43